HEALTH DECISIONS, INC.: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2020 (FY2021), from USAspending.gov. UEI: CMKQYLSLNJG1
15contracts won
$56,563,986total obligated
$2,493,065median contract
Sep 20, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 15 | $56,563,986 |
Where it works
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| NICHD:R&D:CCTN STATISTICAL AND CLINICAL COORDINATING CENTER (SCCC) CORE FUNCTION ACTIVITIES:SEVERABLE
75N94026F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$495,123 | Sep 20, 2026 Ends: Sep 19, 2027 |
| NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE
75N94025F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Durham, NC |
— | Department of Health and Human Services National Institutes of Health |
$1,286,724 Potential value: $2,355,840 |
Aug 01, 2025 Ends: Mar 31, 2028 |
| NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTR…
75N94025F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Durham, NC |
— | Department of Health and Human Services National Institutes of Health |
$1,230,826 | May 01, 2025 Ends: Oct 31, 2027 |
| PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC …
75N94024F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$994,099 | Sep 25, 2024 Ends: Sep 24, 2027 |
| ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING
75N94024F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$1,199,999 | Sep 25, 2024 Ends: Sep 25, 2026 |
| FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL
75N94023F00003 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$2,187,390 | Sep 01, 2023 Ends: Jul 31, 2027 |
| STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTI…
75N94023F00002 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$2,330,144 | May 25, 2023 Ends: Oct 21, 2026 |
| COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
75N94023F00001 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$6,449,482 | Jan 01, 2023 Ends: Apr 30, 2025 |
| TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION
75N94019F00126 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$2,493,065 | Sep 24, 2019 Ends: Dec 31, 2028 |
| TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COO…
75N94019F00125 · NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$3,594,685 | Sep 20, 2019 Ends: Sep 19, 2026 |
| HHSN275201200002I/HHSN27500009 - CONTRACEPTIVE CLINICAL TRIALS NETWORK, CLINICAL EVALUATION OF LARC METHODS TO DETERMINE COMPARATIVE EFFECTI…
75N94018F00009 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$9,779,723 | Jul 20, 2018 Ends: Mar 31, 2024 |
| IGF::OT::IGF STATISTICAL AND CLINICAL COORDINATING CENTER FOR CCTN
HHSN27500007 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$3,945,011 | Jul 20, 2017 Ends: Oct 31, 2024 |
| IGF::OT::IGF COORDINATION OF CLINICAL TRIALS OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION
HHSN27500008 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$10,032,586 | Jul 18, 2017 Ends: Jul 17, 2024 |
| IGF::OT::IGF CONTRACEPTIVE CLINICAL TRIALS NETWORK TO6 - COORDINATION OF CLINICAL TRIALS OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION -
HHSN27500006 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$7,374,299 | Apr 13, 2016 Ends: Apr 30, 2025 |
| IGF::OT::IGF EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS OF CONTRACEPTIVE EFFICACY AND SAFETY OF MULTIPURPOSE PREVE…
HHSN27500005 · NAICS 541712 Research and development in the physical, engineering, and life sciences (except biotechnology) · Morrisville, NC |
— | Department of Health and Human Services National Institutes of Health |
$3,170,829 | Sep 24, 2013 Ends: Dec 31, 2025 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.